Gong, Y.; Nagarathinam, R.; Arisi, M.F.; Gerratana, L.; Winn, J.S.; Slifker, M.; Pei, J.; Cai, K.Q.; Hasse, Z.; Obeid, E.;
et al. Genetic Variants and Tumor Immune Microenvironment: Clues for Targeted Therapies in Inflammatory Breast Cancer (IBC). Int. J. Mol. Sci. 2021, 22, 8924.
https://doi.org/10.3390/ijms22168924
AMA Style
Gong Y, Nagarathinam R, Arisi MF, Gerratana L, Winn JS, Slifker M, Pei J, Cai KQ, Hasse Z, Obeid E,
et al. Genetic Variants and Tumor Immune Microenvironment: Clues for Targeted Therapies in Inflammatory Breast Cancer (IBC). International Journal of Molecular Sciences. 2021; 22(16):8924.
https://doi.org/10.3390/ijms22168924
Chicago/Turabian Style
Gong, Yulan, Rajeswari Nagarathinam, Maria F. Arisi, Lorenzo Gerratana, Jennifer S. Winn, Michael Slifker, Jianming Pei, Kathy Q. Cai, Zachary Hasse, Elias Obeid,
and et al. 2021. "Genetic Variants and Tumor Immune Microenvironment: Clues for Targeted Therapies in Inflammatory Breast Cancer (IBC)" International Journal of Molecular Sciences 22, no. 16: 8924.
https://doi.org/10.3390/ijms22168924
APA Style
Gong, Y., Nagarathinam, R., Arisi, M. F., Gerratana, L., Winn, J. S., Slifker, M., Pei, J., Cai, K. Q., Hasse, Z., Obeid, E., Noriega, J., Sebastiano, C., Ross, E., Alpaugh, K., Cristofanilli, M., & Fernandez, S. V.
(2021). Genetic Variants and Tumor Immune Microenvironment: Clues for Targeted Therapies in Inflammatory Breast Cancer (IBC). International Journal of Molecular Sciences, 22(16), 8924.
https://doi.org/10.3390/ijms22168924